EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Vein-first versus artery-first ligation procedure for lung cancer surgery: An updated review.

Authors

Zhao, Tian; Zhang, Chu; Zhao, Chen; Wu, Wen-Bin; Zhang, Miao

Abstract

<bold>Background: </bold>The optimal sequence of pulmonary vessel interruption during lung cancer resection remains controversial. This review aimed to elucidate the association of vein-first versus artery-first ligation and survival of the patients.<bold>Methods: </bold>We searched PubMed, Web of Science, Scopus, Embase, Cochrane Library and Google Scholar from their inception to September 2021 for published articles that compared vein-first (the pulmonary vein was interrupted first) and artery-first procedure (the pulmonary artery was ligated first) during lung cancer surgery.<bold>Results: </bold>Finally, a total of 13 full articles were obtained. First, 7 studies with survival information were included for meta-analyses. As compared with the artery-first ligation, vein-first approach did not decrease the risk of local recurrence (risk ratio [RR] 0.92 in favour of vein-first; 95% confidence interval [CI] 0.61-1.39, p = 0.68) or distant metastasis (RR 0.92; 95% CI 0.30-2.85, p = 0.89); but it was associated with better disease-free survival (RR 0.52; 95% CI 0.37-0.73, p < 0.01) as well as 5-year overall survival (RR 0.60; 95% CI 0.41-0.86, p < 0.01). In addition, the operative time, intraoperative blood loss, total complications, and length of postoperative stay were mainly comparable between the two groups. Second, 7 studies provided the data of tumor cells indicated by different biomarkers and detection methods; and 3 of these reports showed that vein-first ligation decreased the extent of intraoperative tumor dissemination. However, a quantitative meta-analysis was not possible due to the significant heterogeneity.<bold>Conclusion: </bold>Vein-first ligation in lung cancer surgery may be associated with improved survival of the patients, which might be ascribed to potentially lower risk of tumor cell dissemination. Well-designed, large-scale trials are warranted to clarify these occasional findings.

Subjects

GOOGLE Scholar (Web resource); LUNG surgery; LUNG cancer; OVERALL survival; CANCER invasiveness; SURGICAL blood loss; ONCOLOGIC surgery; META-analysis; SYSTEMATIC reviews; LUNG tumors; PULMONARY artery; CANCER relapse; PNEUMONECTOMY; LIGATURE (Surgery)

Publication

Journal of Cardiothoracic Surgery, 2021, Vol 16, Issue 1, p1

ISSN

1749-8090

Publication type

Academic Journal

DOI

10.1186/s13019-021-01658-w

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved